Medon Clinical Researchsp. z o.o.
Other research and experimental development on natural sciences and engineering
KRS: NIP: REGON:
Overview
Status
Active
Registry date
2024-04-19
Share capital
6,000.00 PLN
Average employment (people)
1 (2025)
Registered address
ul. Piękna 24/26A, 00-549 Warszawa, Poland
Financials
Revenue history (in k)
Financial insight
- Possible Estonian CIT: Equity includes Art. 28d line items, but all amounts are 0 – this may be an accounting template or the first year of the regime.
From the notes
| Profit allocation | Loss covered | |
| Loans and borrowings | $84,756 |
Filing timeliness
2 of 2 financial statements were filed late (the longest delay 77 days for 2025).
- 202530/09/2026
- 202418/07/2025
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Industry · Other research and experimental development on natural sciences and engineering754 / 1,565
Top 48%
Results vs industry
Revenue
This companyUSD 82.89kMedianUSD 73.26kAverageUSD 3.23m
Net profit
This companyUSD -71.73kMedianUSD 69.70AverageUSD 82.18k
Operating costs
This companyUSD 146.72kMedianUSD 75.78kAverageUSD 3.04m
Assets
This companyUSD 31.02kMedianUSD 119.88kAverageUSD 3.90m
Industry
Authorized Representatives
Marta Alicja Moczydłowska – President of the Management Board
Michał Karol Fedorczyk – Management Board Member
Manner of representation
Each member of the management board is authorized to make declarations on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Michał Karol Fedorczykage 39 | 30 | $810.37 | 50% |
Marta Alicja Moczydłowskaage 36 | 30 | $810.37 | 50% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2024-04-27.
43 1020 1127 0000 1902 0424 2442
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| 4ATsp. z o.o. | $4,252.39 | 4at.pl | ||
| 2loop Techsp. z o.o. | $3,513.01 | 2loop.tech | ||
| Microanalysissp. z o.o. | $1,425.98 | microanalysis.pl | ||
| DEEP Technologysp. z o.o. | $1,202.71 | deeptechnology.ai | ||
| Magowiesp. z o.o. | $1,104.97 | magowie.pl | ||
| L-Conesp. z o.o. | $803.90 | l-cone.pl | ||
| FEW Forms R&Dsp. z o.o. | $747.53 | fewforms.com | ||
| Empyriosp. z o.o. | $753.70 | empyrio.com | ||
| Azimuthe Automationsp. z o.o. | $753.39 | azimuthe.com | ||
| Nevomo Iotsp. z o.o. | $502.62 | nevomo.tech |
FAQ
The main business activity of Medon Clinical Research focuses on other research and experimental development on natural sciences and engineering.
The company was registered in the Polish National Court Register (KRS) on April 19, 2024.
The headquarters is located at: ul. Piękna 24/26A, 00-549 Warszawa.
The share capital of the company is PLN 6,000 (approx. $1,621).
The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.
In 2025, the company generated total revenue of USD 82,886, representing an increase of 9583.8% compared to 2024.
No, the company recorded a net loss of USD 71,733 in 2025. For comparison, in 2024 the loss was USD 33,672, meaning the company increased its loss by 112.6%.
The largest operating cost category falls under external services. This category amounted to USD 108,933 in 2025, representing 74% of all operating expenses.
Last updated: 2026-09-30